TITLE

Jubilant Q2 profits double on higher sales

PUB. DATE
November 2007
SOURCE
Chemical Business;Nov2007, Vol. 21 Issue 11, p76
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the increase in net profits of Jubilant Organosys, the pharmaceutical and Custom Research and Manufacturing Services (CRAMS) company in India, for the second quarter ended September 30, 2007. There was an almost 33% increase in the consolidated net sales of Jubilant. Half of its revenues is attributed to the clinical research and services business for international pharmaceuticals. It notes that market growth is accounted for almost a quarter of total sales.
ACCESSION #
31156717

 

Related Articles

  • Jubilant net profit up 31.7%.  // Chemical Business;May2006, Vol. 20 Issue 5, p70 

    Reports on the increase in the net profit of Jubilant Organosys for the fourth quarter of 2005 to 2006. Increase in the company's net sales; Growth of the pharmaceuticals and life science chemicals; Approval of a proposal to raise funds through private placement of shares.

  • Forex losses eat into Jubilant's margins.  // Chemical Business;May2008, Vol. 22 Issue 5, p59 

    The article reports on a drop in fourth quarter 2008 profit posted by Indian pharmaceutical company Jubilant Organosys Ltd., due to foreign exchange losses. The company reported an 8.8 per cent year-on-year drop in fourth-quarter net profit. The company recorded a foreign exchange loss of Rs...

  • Custom Manufacturers' Results Improve. Scott, Alex // Chemical Week;8/10/2005, Vol. 167 Issue 26, p29 

    Focuses on several manufacturers of custom pharmaceutical intermediates that posted improvements in sales and earnings in their financial reports as of August 10, 2005. Lonza; Cambrex; Hovione; Jubilant Organysis.

  • Jubilant Focuses on Growth from Regulated Markets in Europe and the U.S. Ramesh, Deepti // Chemical Week;9/19/2007, Vol. 169 Issue 30, p42 

    The article reports on the statement issued by Jubilant Organosys that the regulated markets of Europe and the U.S. are among its priorities and that it expects substantial growth in international sales. The company's international sales for first-quarter 2008, which runs from April-June 2007,...

  • Jubilant Extends Presence in Western Markets. Scott, Alex // Chemical Week;11/15/2006, Vol. 168 Issue 38, p20 

    The article reports that Jubilant Organosys of Noida, India, India's largest drug discovery and pharmaceuticals services company, says that its business continues to grow faster in developed markets than in India. The company disclosed that profits for its fiscal second quarter, ended September...

  • Big Growth in CRAMS Contracts for Jubilant.  // Chemical Week;4/4/2007, Vol. 169 Issue 12, p5 

    The article focuses on the custom research and manufacturing services (CRAMS) contracts received by Jubilant Organosys Co. of Noida, India. Jubilant, one of India's largest drug discovery and pharmaceutical services companies, says it has signed several CRAMS contracts worth a combined $60...

  • Jubilant Organosys posts 40% growth in Q3 net.  // Chemical Business;Feb2008, Vol. 22 Issue 2, p66 

    This article reports on the financial performance of Jubilant Organosys in the third quarter of 2007. Jubilant posted an increase in consolidated net profits during the period. Chairman and managing director Shyam S. Bhartia attributed the growth the expansion of the business. The industrial and...

  • Jubilant Organosys fourth quarter net up at Rs 63.8 cr.  // Chemical Business;May2007, Vol. 21 Issue 5, p74 

    The article reports on the increase in the net profit of Jubilant Organosys. It is stated that the company's net profit has reached Rs 63.8 crore for the fourth quarter ended March 31, 2007, as the sales has improved to Rs 463 crore during the quarter. According to Shyam S. Bhartia, chairman and...

  • Tightening the Connection with India. Ruth, João-Pierre S. // njbiz;11/13/2006, Vol. 19 Issue 46, p15 

    The article features Clinsys, a company which provides clinical research and data-management services to drugmakers, acquired by India's Jubilant Organosys. Clinsys has 150 workers across the U.S. and about 100 employees in India. The company created a business and culture program for employees...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics